Works matching IS 0741238X AND DT 2021 AND VI 38 AND IP 4


Results: 20
    1
    3
    4
    5
    6
    7
    8
    9
    10
    11
    13
    14
    15
    16
    17
    18
    19
    20

    Efficacy and Safety of the Biosimilar IBI301 Plus Standard CHOP (I-CHOP) in Comparison With Rituximab Plus CHOP (R-CHOP) in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A Randomized, Double-Blind, Parallel-Group, Phase 3 Trial.

    Published in:
    2021
    By:
    • Song, Yuqin;
    • Zhou, Hui;
    • Zhang, Huilai;
    • Liu, Wei;
    • Shuang, Yuerong;
    • Zhou, Keshu;
    • Lv, Fangfang;
    • Xu, Hao;
    • Zhou, Jianfeng;
    • Li, Wei;
    • Wang, Huaqing;
    • Zhang, Hongyu;
    • Huang, Haiwen;
    • Zhang, Qingyuan;
    • Xu, Wei;
    • Ge, Zheng;
    • Xiang, Ying;
    • Wang, Shuye;
    • Gao, Da;
    • Yang, Shun'e
    Publication type:
    journal article